Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.96 USD | -18.48% | -19.55% | +34.87% |
05-10 | Iovance Biotherapeutics' Patient Selection for Amtagvi Launch Minimizing Attrition, Truist Securities Says | MT |
05-10 | Iovance Biotherapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.87% | 3.07B | |
-27.67% | 9.87B | |
-17.30% | 2.73B | |
-11.15% | 2.24B | |
-22.32% | 1.63B | |
+59.69% | 1.39B | |
+23.58% | 771M | |
-1.31% | 760M | |
-28.57% | 516M | |
+5.37% | 310M |
- Stock Market
- Equities
- IOVA Stock
- News Iovance Biotherapeutics, Inc.
- Iovance Biotherapeutics Insider Bought Shares Worth $292,800, According to a Recent SEC Filing